Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 41 of 41 entries
Sorted by: Best Match Show Resources per page
Therapy Delayed is Therapy Denied: A Case Report of Melanoma Misdiagnosed as Diabetic Foot Ulcer.

Clinical, cosmetic and investigational dermatology

Nwabudike LC, Oproiu AM, Dogaru IM, Costache M, Onisor C, Tatu AL.
PMID: 35002272
Clin Cosmet Investig Dermatol. 2021 Dec 29;14:1909-1912. doi: 10.2147/CCID.S337545. eCollection 2021.

Malignant melanoma is a deadly form of skin cancer, and prompt diagnosis is a key factor in providing adequate, life-saving therapy. A 75-year-old man, with long-standing type 2 diabetes mellitus, presented with a 2- to 3-year history of right...

Low Field Optimization of a Non-Contacting High-Sensitivity GMR-Based DC/AC Current Sensor.

Sensors (Basel, Switzerland)

Mușuroi C, Oproiu M, Volmer M, Neamtu J, Avram M, Helerea E.
PMID: 33917498
Sensors (Basel). 2021 Apr 06;21(7). doi: 10.3390/s21072564.

Many applications require galvanic isolation between the circuit where the current is flowing and the measurement device. While for AC, the current transformer is the method of choice, in DC and, especially for low currents, other sensing methods must...

GITMO REGISTRY STUDY ON ALLOGENEIC TRANSPLANTATION IN PATIENTS AGED OVER 60 FROM 2000 TO 2017. IMPROVEMENTS AND CRITICISMS.

Transplantation and cellular therapy

Malagola M, Polverelli N, Rubini V, Martino M, Patriarca F, Bruno B, Giaccone L, Grillo G, Bramanti S, Bernasconi P, De Gobbi M, Natale A, Terruzzi E, Olivieri A, Chiusolo P, Carella AM, Casini M, Nozzoli C, Mazza P, Bassi S, Onida F, Vacca A, Falcioni S, Luppi M, Iori AP, Pavone V, Skert C, Carluccio P, Borghero C, Proia A, Selleri C, Sacchi N, Mammoliti S, Oldani E, Ciceri F, Russo D, Bonifazi F.
PMID: 34818581
Transplant Cell Ther. 2021 Nov 21; doi: 10.1016/j.jtct.2021.11.006. Epub 2021 Nov 21.

BACKGROUND: Nowadays, allogeneic stem cell transplantation (Allo-SCT) can be offered to patients up to the age of 70-72 years and represents one of the most effective curative treatments for many hematological malignancies.OBJECTIVES: The primary objective of the study is...

GITMO Registry Study of Allogeneic Transplantation in Patients Age >60 Years, 2000 to 2017: Improvements and Criticisms.

Transplantation and cellular therapy

Malagola M, Polverelli N, Rubini V, Martino M, Patriarca F, Bruno B, Giaccone L, Grillo G, Bramanti S, Bernasconi P, De Gobbi M, Natale A, Terruzzi E, Olivieri A, Chiusolo P, Carella AM, Casini M, Nozzoli C, Mazza P, Bassi S, Onida F, Vacca A, Falcioni S, Luppi M, Iori AP, Pavone V, Skert C, Carluccio P, Borghero C, Proia A, Selleri C, Sacchi N, Mammoliti S, Oldani E, Ciceri F, Russo D, Bonifazi F.
PMID: 34818581
Transplant Cell Ther. 2021 Nov 21; doi: 10.1016/j.jtct.2021.11.006. Epub 2021 Nov 21.

Today, allogeneic stem cell transplantation (allo-SCT) can be offered to patients up to age 70 to 72 years and represents one of the most effective curative treatments for many hematologic malignancies. The primary objective of the study was to...

Therapy Delayed is Therapy Denied: A Case Report of Melanoma Misdiagnosed as Diabetic Foot Ulcer.

Clinical, cosmetic and investigational dermatology

Nwabudike LC, Oproiu AM, Dogaru IM, Costache M, Onisor C, Tatu AL.
PMID: 35002272
Clin Cosmet Investig Dermatol. 2021 Dec 29;14:1909-1912. doi: 10.2147/CCID.S337545. eCollection 2021.

Malignant melanoma is a deadly form of skin cancer, and prompt diagnosis is a key factor in providing adequate, life-saving therapy. A 75-year-old man, with long-standing type 2 diabetes mellitus, presented with a 2- to 3-year history of right...

Showing 37 to 41 of 41 entries